Business · 14/10/1994
National Cancer Institute Seeks Biotech Partner for Fluorescent PCR Visualization Technique
The National Cancer Institute is seeking a biotechnology company to collaborate on the development of a novel fluorescent guanosine analog for visualizing PCR products, with the potential for a Cooperative Research and Development Agreement (CRADA).
Original source language: Federal Register — Health and Human ServicesOpen original release →